Importantly, several studies also suggested that PGS can modify the penetrance of BRCA2 PV carriers for several cancers, including breast and prostate cancer [28, 29, 30, 31, 32, 33, 34, 35, 36, 37]. This evidence concerns the gene BRCA2 and Familial prostate cancer.